These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35765923)
1. Proposed Risk Stratification and Patterns of Radioactive Iodine Therapy in Malignant Struma Ovarii. Egan C; Stefanova D; Thiesmeyer JW; Lee YJ; Greenberg J; Beninato T; Zarnegar R; Christos PJ; Klein IL; Fahey TJ; Finnerty BM Thyroid; 2022 Sep; 32(9):1101-1108. PubMed ID: 35765923 [No Abstract] [Full Text] [Related]
2. Clinical Manifestations of Malignant Struma Ovarii: A Retrospective Case Series in a Tertiary Hospital in Korea. Ryu HJ; Leem DE; Yoo JH; Kim TH; Kim SW; Chung JH Endocrinol Metab (Seoul); 2024 Jun; 39(3):461-467. PubMed ID: 38721636 [TBL] [Abstract][Full Text] [Related]
3. Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases. Marti JL; Clark VE; Harper H; Chhieng DC; Sosa JA; Roman SA Thyroid; 2012 Apr; 22(4):400-6. PubMed ID: 22181336 [TBL] [Abstract][Full Text] [Related]
4. Malignant struma ovarii: a population-level analysis of a large series of 68 patients. Goffredo P; Sawka AM; Pura J; Adam MA; Roman SA; Sosa JA Thyroid; 2015 Feb; 25(2):211-5. PubMed ID: 25375817 [TBL] [Abstract][Full Text] [Related]
5. The lack of consensus in management of malignant struma ovarii. González Aguilera B; Guerrero Vázquez R; Gros Herguido N; Sánchez Gallego F; Navarro González E Gynecol Endocrinol; 2015 Apr; 31(4):258-9. PubMed ID: 25539066 [TBL] [Abstract][Full Text] [Related]
6. Metastatic malignant struma ovarii to the pituitary presenting as a sellar mass and responding to total thyroidectomy with adjuvant radioactive iodine therapy. Dissanayake A; Liu AY; Gooderham PA; MacKenzie-Feder J BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38834312 [TBL] [Abstract][Full Text] [Related]
7. Presentation and treatment of two cases of malignant struma ovarii. Obeidat RA; Alshwayyat S; Alshwayyat TA; Rjoop A; Sharqiah QM BMC Womens Health; 2024 Mar; 24(1):158. PubMed ID: 38443937 [TBL] [Abstract][Full Text] [Related]
8. Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma. Leong A; Roche PJ; Paliouras M; Rochon L; Trifiro M; Tamilia M J Clin Endocrinol Metab; 2013 Dec; 98(12):4599-605. PubMed ID: 24217901 [TBL] [Abstract][Full Text] [Related]
9. Papillary thyroid cancer in a struma ovarii: a report of a rare case. Monti E; Mortara L; Zupo S; Dono M; Minuto F; Truini M; Naseri M; Giusti M Hormones (Athens); 2015; 14(1):154-9. PubMed ID: 25402391 [TBL] [Abstract][Full Text] [Related]
10. Struma ovarii maligna. Matysiak-Grzes M; Fischbach J; Gut P; Klimowicz A; Gryczynska M; Wasko R; Ruchala M Neuro Endocrinol Lett; 2013; 34(2):97-101. PubMed ID: 23645304 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and survival outcomes of malignant struma ovarii confined to the ovary. Li S; Yang T; Xiang Y; Li X; Zhang L; Deng S BMC Cancer; 2021 Apr; 21(1):383. PubMed ID: 33836675 [TBL] [Abstract][Full Text] [Related]
12. Management of malignant struma ovarii: is aggressive therapy justified? Case report and literature review. Leuștean L; Ungureanu MC; Preda C; Bilha SC; Obrocea F; Dănilă R; Stătescu L; Apostol Ciobanu DG Thyroid Res; 2022 Aug; 15(1):14. PubMed ID: 35948940 [TBL] [Abstract][Full Text] [Related]
13. Radioactive iodine in differentiated thyroid cancer: a national database perspective. Orosco RK; Hussain T; Noel JE; Chang DC; Dosiou C; Mittra E; Divi V; Orloff LA Endocr Relat Cancer; 2019 Oct; 26(10):795-802. PubMed ID: 31443087 [TBL] [Abstract][Full Text] [Related]
14. Missed Initial Diagnosis of Malignant Struma Ovarii Containing Follicular Thyroid Carcinoma: Metastatic Pulmonary Recurrence 17 yr After Ovariectomy. Cong H; Li T; Chen G; Liang Z; Liang J; Lin Y Int J Gynecol Pathol; 2015 Sep; 34(5):445-9. PubMed ID: 26262453 [TBL] [Abstract][Full Text] [Related]
15. Malignant struma ovarii: From case to analysis. Ayhan S; Kilic F; Ersak B; Aytekin O; Akar S; Turkmen O; Akgul G; Toyran A; Turan T; Kimyon Comert G J Obstet Gynaecol Res; 2021 Sep; 47(9):3339-3351. PubMed ID: 34219334 [TBL] [Abstract][Full Text] [Related]
16. Synchronous thyroid cancer and malignant struma ovarii: concordant mutations and microRNA profile, discordant loss of heterozygosity loci. Seo GT; Minkowitz J; Kapustin DA; Fan J; Minkowitz G; Minkowitz M; Dowling E; Matloob A; Asti D; Dhar M; Shutty C; Brickman A; Urken ML; Brandwein-Weber M; Finkelstein SD Diagn Pathol; 2023 Apr; 18(1):47. PubMed ID: 37072862 [TBL] [Abstract][Full Text] [Related]
17. TIMING OF RADIOACTIVE IODINE THERAPY DOES NOT IMPACT OVERALL SURVIVAL IN HIGH-RISK PAPILLARY THYROID CARCINOMA. Suman P; Wang CH; Abadin SS; Block R; Raghavan V; Moo-Young TA; Prinz RA; Winchester DJ Endocr Pract; 2016 Jul; 22(7):822-31. PubMed ID: 27018620 [TBL] [Abstract][Full Text] [Related]
18. Radiotherapy with iodine-131 in recurrent malignant struma ovarii. Brenner W; Bohuslavizki KH; Wolf H; Sippel C; Clausen M; Henze E Eur J Nucl Med; 1996 Jan; 23(1):91-4. PubMed ID: 8586108 [TBL] [Abstract][Full Text] [Related]
19. Papillary thyroid carcinoma in Struma Ovarii. Khatchapuridze K; Kekelidze N; Tsitsishvili Z; Mchedlishvili M; Kordzaia D Gynecol Endocrinol; 2020 Aug; 36(8):749-752. PubMed ID: 32041443 [TBL] [Abstract][Full Text] [Related]
20. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer. Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]